Clover Biopharmaceuticals, Ltd. (HKG:2197)
Hong Kong · Delayed Price · Currency is HKD 1.600
-0.010 (-0.62%)
Jun 18, 2026, 11:30 AM HKT
Clover Biopharmaceuticals Market Cap
Clover Biopharmaceuticals has a market cap or net worth of 2.09 billion as of June 17, 2026. Its market cap has increased by 632.37% in one year.
Market Cap
2.09B
Enterprise Value
1.79B
Revenue
3.90M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.60
Market Cap Chart
Since November 5, 2021, Clover Biopharmaceuticals's market cap has decreased from 15.03B to 2.09B, a decrease of -86.10%. That is a compound annual growth rate of -34.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 2.09B | -31.19% |
| Dec 31, 2025 | 3.04B | 871.54% |
| Dec 31, 2024 | 312.59M | -61.08% |
| Dec 29, 2023 | 803.26M | -76.01% |
| Dec 30, 2022 | 3.35B | -78.71% |
| Dec 31, 2021 | 15.73B | 4.62% |
| Nov 5, 2021 | 15.03B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TYK Medicines | 2.65B |
| Beijing Luzhu Biotechnology | 2.46B |
| Viva Biotech Holdings | 2.45B |
| AIM Vaccine | 2.40B |
| Antengene Corporation | 2.40B |
| Frontage Holdings | 2.03B |
| SinoMab BioScience | 1.79B |
| HighTide Therapeutics | 1.63B |